Abbvie (ABBV) announced an update on their ongoing clinical study. AbbVie recently completed a clinical study titled ‘Venetoclax (Venclexta Tablet) Post-Marketing Surveillance for AML Patients.’ The ...
A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute myeloid leukemia (AML) is driving better survival and cure rates. Led by Mikkael ...
Beyond Analysis has launched a new sister company Beyond AML which will assist financial institutions to leverage applied intelligence, data analytics and machine learning to optimise their end-to-end ...
AUSTIN, TX and DURHAM, NC, May 14, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback